226 related articles for article (PubMed ID: 17727372)
1. Cutaneous metastasis as the first clinical manifestation of pancreatic adenocarcinoma: a case treated with gemcitabine.
Takemura N; Fujii N; Tanaka T
J Dermatol; 2007 Sep; 34(9):662-4. PubMed ID: 17727372
[No Abstract] [Full Text] [Related]
2. Cutaneous metastasis of pancreatic adenocarcinoma after kidney transplant: a case report and review of the literature.
Pontinen T; Melin A; Varadi G; Khanmoradi K; Chewaproug D; Kung SC; Zaki R; Ortiz J
Exp Clin Transplant; 2010 Dec; 8(4):273-6. PubMed ID: 21143091
[TBL] [Abstract][Full Text] [Related]
3. Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?
Kourie HR; Gharios J; Kattan J
Future Oncol; 2017 Feb; 13(3):197-199. PubMed ID: 27624286
[No Abstract] [Full Text] [Related]
4. Solitary cutaneous metastasis on the buttock: a disclosing sign of pancreatic adenocarcinoma.
Flórez A; Rosón E; Sánchez-Aguilar D; Peteiro C; Toribio J
Clin Exp Dermatol; 2000 May; 25(3):201-3. PubMed ID: 10844494
[TBL] [Abstract][Full Text] [Related]
5. Unprecedented case of tumor lysis syndrome in a patient with metastatic pancreatic adenocarcinoma.
Ling W; Sachdeva P; Wong AS; Lee SC; Zee YK
Pancreas; 2012 May; 41(4):659-61. PubMed ID: 22504387
[No Abstract] [Full Text] [Related]
6. Sudden cardio-pulmonary toxicity following a single infusion of gemcitabine.
Ciotti R; Belotti G; Facchi E; Cantù A; D'Amico A; Gatti C
Ann Oncol; 1999 Aug; 10(8):997. PubMed ID: 10509166
[No Abstract] [Full Text] [Related]
7. Gemcitabine-induced hepatitis in a pancreatic cancer patient receiving adjuvant therapy following metastasectomy.
Saadati H; Peccerillo J; Kaley K; Schilsky ML; Saif MW
JOP; 2009 Sep; 10(5):573-5. PubMed ID: 19734642
[No Abstract] [Full Text] [Related]
8. [Gemcitabine treatment of pancreatic cancer peritonitis].
Horiki N; Maruyama M; Fujita Y; Suzuki Y; Tanaka T; Shimomura M; Tanigawa K; Sasaki H; Fujiwara M; Suzuki K; Imoto I; Adachi Y
Nihon Shokakibyo Gakkai Zasshi; 2003 Jan; 100(1):73-8. PubMed ID: 12601933
[No Abstract] [Full Text] [Related]
9. Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer.
Boeck S; Heinemann V
J Clin Oncol; 2008 Mar; 26(7):1178-9; author reply 1179. PubMed ID: 18309957
[No Abstract] [Full Text] [Related]
10. [A case of advanced pancreatic cancer treated with gemcitabine hydrochloride].
Taniguchi F; Matsuda T; Tsuda T; Aikawa I
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1147-9. PubMed ID: 12938271
[TBL] [Abstract][Full Text] [Related]
11. Treatment of metastatic pancreatic cancer.
Ko AH; Tempero MA
J Natl Compr Canc Netw; 2005 Sep; 3(5):627-36. PubMed ID: 16194454
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine: a ray of hope for pancreatic cancer?
Gupta P
Natl Med J India; 1997; 10(2):72-3. PubMed ID: 9153984
[No Abstract] [Full Text] [Related]
13. [A long-term survivor case with good quality of life due to biliary bypass and gemcitabine for advanced pancreatic cancer].
Maeyama R; Fukuyama T; Morimatsu K; Tamura T; Ishikawa N; Hachiya Y; Sako T; Hirano Y
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1873-5. PubMed ID: 18030028
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer.
Maisonneuve P; Lowenfels AB
JAMA; 2007 Jun; 297(23):2581; author reply 2582. PubMed ID: 17579223
[No Abstract] [Full Text] [Related]
15. Uptake and patterns of use of gemcitabine for metastatic pancreatic cancer: a population-based study.
Oberstein PE; Hershman DL; Khanna LG; Chabot JA; Insel BJ; Neugut AI
Cancer Invest; 2013 Jun; 31(5):316-22. PubMed ID: 23614655
[TBL] [Abstract][Full Text] [Related]
16. Unresectable pancreatic adenocarcinoma treated with palladium-103 implant and chemoradiation.
Parikh S; Nori D
J Clin Gastroenterol; 1998 Mar; 26(2):158-60. PubMed ID: 9563935
[No Abstract] [Full Text] [Related]
17. [A case of advanced pancreatic cancer showing remarkable response to gemcitabine treatment].
Masaki T; Ohkawa S; Hirokawa S; Miyakawa K; Tamai S; Tarao K
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1333-6. PubMed ID: 14518416
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine resistance in pancreatic cancer: picking the key players.
Kim MP; Gallick GE
Clin Cancer Res; 2008 Mar; 14(5):1284-5. PubMed ID: 18316544
[No Abstract] [Full Text] [Related]
19. Gemcitabine associated pseudocellulitis.
Singh A; Hampole H
J Gen Intern Med; 2012 Dec; 27(12):1721. PubMed ID: 22696254
[No Abstract] [Full Text] [Related]
20. Locally advanced pancreatic cancer: where should we go from here?
Philip PA
J Clin Oncol; 2011 Nov; 29(31):4066-8. PubMed ID: 21969514
[No Abstract] [Full Text] [Related]
[Next] [New Search]
